Duloxetine

Articles · Medicine Compliance Aid Stability · Lactation Safety Information ·

407033009

Articles

Medicine Compliance Aid Stability

Cymbalta · Eli Lilly and Co Ltd

Eli Lilly and Co Ltd
Cymbalta
Capsules 30mg, 60mg
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture.
26th October 2015

Yentreve · Eli Lilly and Co Ltd

Eli Lilly and Co Ltd
Yentreve
Capsules 20mg, 40mg
R2 · Red 2 · Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Protect from moisture. Store in original pack
21st September 2015

generic · Dr Reddy's Laboratories (UK) Ltd

Dr Reddy's Laboratories (UK) Ltd
generic
Capsules 30mg, 60mg
G2 · Green 2 · No stability data is available, but manufacturer suggests it is suitable for use in CAs.
Protect from light
Protect from moisture
Protect from light. Protect from moisture. Max 28 days in MCA.
26th October 2015

Lactation Safety Information

For depression

For depression
TCA: imipramine/nortriptyline SSRI: paroxetine/sertraline
Limited published evidence of safety
Small amounts found in breast milk that are likely to be degraded in infant’s GI tract, although relatively long half life increases risk of accumulation in breastfed infants
Monitor infant for drowsiness, poor feeding, irritability/behavioural effects
17th September 2018

For urinary incontinence

For urinary incontinence
Limited published evidence of safety
Small amounts in breast milk that are likely to be degraded in infant’s GI tract, although long half life increases risk of accumulation in breast fed infants
Monitor infant for drowsiness, poor feeding, irritability/ behavioural effects
17th September 2018